AG21 Health Sciences
AG21 Health Sciences focuses on licensing patented antimicrobial technology and advancing antimicrobial and wound-healing products. The organization reports development of a patented chelated silver–chitosan antimicrobial complex formulated with natural antimicrobials, sponsorship of GLP testing to validate antimicrobial and healing properties, and a restructuring of resources to support entry into the professional wound care market. Stated market areas include OTC/first aid, animal health, professional wound care, and dental.
Industries
Nr. of Employees
small (1-50)
AG21 Health Sciences
Products
Patented chelated silver–chitosan antimicrobial complex
A patented chelated silver–chitosan antimicrobial complex formulated with natural antimicrobials, developed for antimicrobial activity and wound-healing applications.
Patented chelated silver–chitosan antimicrobial complex
A patented chelated silver–chitosan antimicrobial complex formulated with natural antimicrobials, developed for antimicrobial activity and wound-healing applications.
Services
Technology licensing
Licensing of patented antimicrobial technology to partners and product developers.
Technology licensing
Licensing of patented antimicrobial technology to partners and product developers.
Expertise Areas
- Antimicrobial product development
- Wound care therapeutics
- Formulation chemistry and product commercialization
- GLP-compliant preclinical testing and validation
Key Technologies
- Chelated silver–chitosan antimicrobial complexes
- Natural antimicrobial agents and chelation chemistry
- Formulation chemistry methods
- GLP testing protocols